Ginkgo Bioworks Holdings, Inc. - 8-K Filing
Ginkgo Bioworks schedules Q3 2026 business performance presentation for November 5, 2026. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $DNA
Read the full article at SEC EDGAR
Part of the story Liberty Latin America Ltd. - 8-K Filing (5 articles)